Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Advanced Chronic Lymphocytic Leukemia (CLL) Fludarabine, Mitoxantrone and Cyclophosphamide With or Without G-CSF

NCT00416910 is registered in ClinicalTrials.gov with German CLL Study Group as lead sponsor.

NCT NCT00416910
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00416910 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Advanced Chronic Lymphocytic Leukemia (CLL) Fludarabine, Mitoxantrone and Cyclophosphamide With or Without G-CSF
Lead sponsor
German CLL Study Group
Phase
Phase 3
Overall status
Terminated
Start date
July 31, 1999
Completion date
September 30, 2007
Enrollment
83 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

chronic lymphocytic leukemia